Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.

Name: Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.
License: Public Domain

Yale University

ClinicalTrials.gov · Datasets · License: Public Domain

carcinoma, non-small-cell lung

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143554
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.